Atlas Trials

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Clinical trial NCT05970744 · COMPLETED

Trial details

NCT number
NCT05970744
Sponsor
Tatyana Zubkova
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Infections
Start date
2023-05-10
Primary completion
2023-06-19
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.